Argyle Capital Management Inc. Eli Lilly & CO Transaction History

Argyle Capital Management Inc.

$248 Million
Q3 2024

A detailed history of Argyle Capital Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Argyle Capital Management Inc. holds 11,527 shares of LLY stock, worth $9.03 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares

11,527

Previous 12,628 8.72%

Holding current value

$9.03 Million

Previous $11.4 Million 10.68%

% of portfolio

4.12%

Previous 4.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $850,126 - $1.06 Million	-1,101 Reduced 8.72%	11,527 $10.2 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $1.02 Million - $1.28 Million	-1,405 Reduced 10.01%	12,628 $11.4 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $2.63 Million - $3.51 Million	-4,434 Reduced 24.01%	14,033 $10.9 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $1.95 Million - $2.3 Million	-3,715 Reduced 16.75%	18,467 $10.8 Million
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $314,722 - $433,893	-724 Reduced 3.16%	22,182 $11.9 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $407,559 - $544,954	-1,162 Reduced 4.83%	22,906 $10.7 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $309,076 - $362,995	-995 Reduced 3.97%	24,068 $8.27 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $131,513 - $153,240	-409 Reduced 1.61%	25,063 $9.17 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $259,716 - $295,974	-876 Reduced 3.32%	25,472 $8.24 Million
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $41,809 - $49,090	-150 Reduced 0.57%	26,348 $8.54 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $252,291 - $313,534	-1,075 Reduced 3.9%	26,498 $7.59 Million
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $127,265 - $157,936	-566 Reduced 2.01%	27,573 $7.62 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $44,320 - $54,541	-200 Reduced 0.71%	28,139 $6.5 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $61,387 - $79,403	-340 Reduced 1.19%	28,339 $6.5 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $169,249 - $219,101	-1,030 Reduced 3.47%	28,679 $5.36 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $151,985 - $201,113	-1,165 Reduced 3.77%	29,709 $5.02 Million
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $43,866 - $50,739	-300 Reduced 0.96%	30,874 $4.57 Million
Q2 2020 Jul 22, 2020	SELL	$136.42 - $164.18 $744,580 - $896,094	-5,458 Reduced 14.9%	31,174 $5.12 Million
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 0.27%	36,632 $5.08 Million
Q4 2019 Jan 24, 2020	SELL	$106.92 - $132.43 $53,460 - $66,215	-500 Reduced 1.34%	36,732 $4.83 Million
Q3 2019 Oct 25, 2019	SELL	$106.79 - $116.16 $32,037 - $34,848	-300 Reduced 0.8%	37,232 $4.16 Million
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $10,017 - $11,791	-90 Reduced 0.24%	37,532 $4.87 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $79,425 - $88,980	-750 Reduced 1.95%	37,622 $4.35 Million
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $5,151 - $6,438	-60 Reduced 0.16%	38,372 $4.12 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $7,570 - $8,688	-100 Reduced 0.26%	38,432 $3.28 Million
Q1 2018 Apr 25, 2018	SELL	$74.21 - $87.6 $103,893 - $122,639	-1,400 Reduced 3.51%	38,532 $2.98 Million
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $3.08 Million - $3.42 Million	39,932	39,932 $3.42 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Eli Lilly & CO Transaction History